Literature DB >> 16885864

Liver abscess after radiofrequency ablation of tumors in patients with a biliary tract procedure.

Dominique Elias1, Daniela Di Pietroantonio, Bertrand Gachot, Paola Menegon, Antoine Hakime, Thierry De Baere.   

Abstract

AIM: The rate of liver abscesses after radiofrequency ablation (RFA) of liver tumors is probably high in patients with a biliary tract drainage procedure connecting the biliary duct system to the upper gastrointestinal tract. And yet, to date this rate, the time of onset of these abscesses, and the prior status of the bile ducts have never been reported in the literature.
METHODS: Among 574 patients treated with RFA over 8 years, only 11 patients (with 13 sessions of RFA, 2 patients undergoing two different RFA sessions) presented with an enterobiliary anastomosis or biliary stenting at the time of RFA. This is a retrospective study of patients who were verified prospectively.
RESULTS: Among the 9 patients in whom a biliary tract procedure preceded RFA, 4 developed a liver abscess at the site of RFA, which emerged between 13 and 62 days after RFA. It occurred in spite of different types of short-term antibiotic prophylaxis. Pathogenic bacteria were typical of the digestive flora. Abscesses were cured after percutaneous drainage. No abscess occurred among the 4 patients in whom a biliary tract diversion was performed synchronously with RFA.
CONCLUSION: When RFA is performed in a patient with a preexisting biliary diversion, the risk of developing a liver abscess is high. Currently, we are unable to recommend any kind of preventive antibiotherapy. A preexisting biliary diversion is not an absolute contraindication for RFA, but the risk of developing a liver abscess is close to 40-50%. When RFA is performed synchronously with a biliary diversion, the risk of a liver abscess seems to disappear.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885864     DOI: 10.1016/s0399-8320(06)73327-9

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  15 in total

Review 1.  Complications of intraoperative radiofrequency ablation of liver metastases.

Authors:  Tsiriniaina Razafindratsira; Milène Isambert; Serge Evrard
Journal:  HPB (Oxford)       Date:  2010-12-07       Impact factor: 3.647

Review 2.  Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.

Authors:  Jianmin Xu; Xinyu Qin; Jianping Wang; Suzhan Zhang; Yunshi Zhong; Li Ren; Ye Wei; Shaochong Zeng; Deseng Wan; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-28       Impact factor: 4.553

Review 3.  Prevention and management of infectious complications of percutaneous interventions.

Authors:  Steven Y Huang; Asher Philip; Michael D Richter; Sanjay Gupta; Mark L Lessne; Charles Y Kim
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

Review 4.  Septic Shock and Death after Microwave Ablation of Hepatocellular Carcinoma in a Liver Transplant Patient with a Bilioenteric Anastomosis.

Authors:  Raymond Melikian; Jeet Minocha
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

5.  Case report. Spontaneous cholecystocolic fistula and locoregional liver tumour ablation: a cautionary tale.

Authors:  U Pua; E M Merkle
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

6.  Use of Prophylactic Antibiotics to Prevent Abscess Formation Following Hepatic Ablation in Patients with Prior Enterobiliary Manipulation.

Authors:  Bruno C Odisio; Michael Richter; Thomas A Aloia; Claudius Conrad; Kamran Ahrar; Sanjay Gupta; Jean-Nicolas Vauthey; Steven Y Huang
Journal:  J Gastrointest Surg       Date:  2016-03-16       Impact factor: 3.452

Review 7.  Complications of radiofrequency ablation of hepatic tumors: Frequency and risk factors.

Authors:  Alexandre Zanchenko Fonseca; Stephanie Santin; Luiz Guilherme Lisboa Gomes; Jaques Waisberg; Marcelo Augusto Fontenelle Ribeiro
Journal:  World J Hepatol       Date:  2014-03-27

8.  Percutaneous ablation of hepatic tumors.

Authors:  James R McCarley; Michael C Soulen
Journal:  Semin Intervent Radiol       Date:  2010-09       Impact factor: 1.513

Review 9.  Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.

Authors:  Susan Shamimi-Noori; Carin F Gonsalves; Colette M Shaw
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

10.  Robot-assisted microwave thermoablation of liver tumors: a single-center experience.

Authors:  L P Beyer; B Pregler; C Niessen; M Dollinger; B M Graf; M Müller; H J Schlitt; C Stroszczynski; P Wiggermann
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-08-26       Impact factor: 2.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.